Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®

View Full Size 

Download

• Full Size JPEG, 1270x458, 65.5 KB
• Small JPEG, 480x173, 25.5 KB
• Preview JPEG, 144x52, 6.2 KB
• Thumbnail JPEG, 120x43, 5.4 KB